DONALD BULLA: Open Payments
NPI 1316055700 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 8 payments from 7 companies in 2025. Trend: 2023 $507 · 2024 $635 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: ELIQUIS, JOURNAVX, ZENPEP, IBSRELA, Wegovy, MAVYRET, Ozempic, RELISTOR.
Industry payments across NC — which companies pay providers there.
